Trump to Meet Pharma Leaders
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
On the revenue side, PBMs get paid by insurance companies to secure rebates from drugmakers in exchange for favorable ...
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...
Legislation that would realign the state’s Medicaid pharmacy benefit under a single state-contracted pharmacy benefit manager ...
The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...
10dOpinion
Lohud.com, Westchester County on MSNCongress must take on Pharmacy Benefit Manager Reform. It's a bipartisan win | OpinionPBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...
New York’s Medicaid program lost an estimated $31.2 million in drug rebates due to rejected pharmacy encounter claims, ...
The 340B Drug Pricing Program (340B Program) is no stranger to controversy. We have previously covered the ongoing contract pharmacy legal battles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results